Sign in
NNBP Stock Price, Chart, Stats & News
Nanobac Pharmaceuticals, Incorporated
Save
Nanobac Pharmaceuticals, Incorporated (NNBP) does not currently pay a dividend.
24,951
Market cap
–
Current P/E
–
Forward P/E
NNBP chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Nanobac Pharmaceuticals, Incorporated is dedicated to advancing human health through the creation and refinement of products and services designed for the identification and management of calcifying nanoparticles (CNPs). The company's offerings include the production and sale of in vitro diagnostic (IVD) kits, which encompass assays, antibodies, and reagents specifically developed for detecting CNPs. Notably, their diagnostic assays include NANO-CAPTURE and NANO-SERO.
Similar securities
Based on sector and market capitalization
Report issue